Clinical Trial Update: Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating switching to DOVATO in patients suppressed on Biktarvy (SOUND).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)
• Dovato (dolutegravir/lamivudine)

Snippet

Sponsor: Saint Michael's Medical Center | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: UNKNOWN